Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cody L. Wolf"'
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Oncostatin M (OSM) is a pleiotropic cytokine involved in a variety of inflammatory responses such as wound healing, liver regeneration, and bone remodeling. As a member of the interleukin-6 (IL-6) family of cytokines, OSM binds the shared receptor gp
Externí odkaz:
https://doaj.org/article/a58efacfd577425cbf43de615390c1da
Autor:
Olga A. Mass, Joseph Tuccinardi, Luke Woodbury, Cody L. Wolf, Bri Grantham, Kelsey Holdaway, Xinzhu Pu, Matthew D. King, Don L. Warner, Cheryl L. Jorcyk, Lisa R. Warner
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract Oncostatin M (OSM) is a pleiotropic, interleukin-6 family inflammatory cytokine that plays an important role in inflammatory diseases, including inflammatory bowel disease, rheumatoid arthritis, and cancer progression and metastasis. Recentl
Externí odkaz:
https://doaj.org/article/9d8f0adf525449bc92eb3e4f5ff6c2f0
Autor:
Ken Tawara, Nicole Ankenbrandt, Cody L. Wolf, Liliana F. Mellor, Jacqueline Emathinger, Hunter Covert, Julie T. Oxford, Cheryl L. Jorcyk
Publikováno v:
Cancer Management and Research. 11:7721-7737
Background Hormone receptor status in human breast cancer cells is a strong indicator of the aggressiveness of a tumor. Triple negative breast cancers (TNBC) are aggressive, difficult to treat, and contribute to high incidences of metastasis by posse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e11c3b6d0647a4026302208b74a2654a
https://doi.org/10.2147/cmar.s208721
https://doi.org/10.2147/cmar.s208721
Autor:
Dollie LaJoie, Laura Bond, Cody L. Wolf, Jacqueline Emathinger, Hannah Scott, Danielle S. Hedeen, Ken Tawara, Cheryl L. Jorcyk, Paul Montgomery (Mentor)
Publikováno v:
Oncotarget
Chronic inflammation has been recognized as a risk factor for the development and maintenance of malignant disease. Cytokines such as interleukin-6 (IL-6), oncostatin M (OSM), and interleukin-1 beta (IL-1β) promote the development of both acute and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0710e48c8f41ef86ae2fc0e5ea109a40
https://doi.org/10.18632/oncotarget.26699
https://doi.org/10.18632/oncotarget.26699
Autor:
Cody L. Wolf, Joey Tuccinardi, Cheryl L. Jorcyk, Cooper McGrath, Lisa R. Warner, Joey Day, Clyde Pruett, Darren J. Lighter, Grace H. Coughlin, Samuel Randall, Matthew D. King, Don L. Warner, Amberlyn Nemeth
Publikováno v:
Cancer Research. 81:1298-1298
Breast cancer is currently the second leading cause of cancer-related deaths and the most commonly diagnosed cancer among women in the Unites States. Localized breast cancer has a five-year survival rate of 99%, however the survival rate for patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eaaf95235559ddaaa7060d0415149a15
https://doi.org/10.1158/1538-7445.am2021-1298
https://doi.org/10.1158/1538-7445.am2021-1298